1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Biomedical Innovation Program (BIP) - Track 1: Device, diagnostic and software is sponsored by Innovate Collaborate Oregon (ICOregon). This funding opportunity from Innovate Collaborate Oregon is intended for medical device and diagnostic technology projects. It supports early-stage development of novel products, processes, or services in the biomedical field.
While biofeedback isn't explicitly mentioned, medical devices are a strong fit.
Get alerted about grants like this
Save a search for “Innovate Collaborate Oregon (ICOregon)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Small businesses in Oregon with projects focused on medical device and diagnostic technology. Confirm the full requirements in the official notice before applying.
The current listing shows up to $40,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Biomedical Innovation Program (BIP) - Track 1: Device, diagnostic and software is funded by Innovate Collaborate Oregon (ICOregon). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Oregon. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Roundhouse funds rural Oregon and Tribal communities exclusively, across arts, education, environmental stewardship, and social services. Its Spring 2026 Open Call alone moved $1.6M to 125 organizations. The Fall Open Call runs June 10 to August 14, 2026. Here is how a place-based family foundation actually evaluates applicants — and how rural nonprofits should approach it.
Read articleNew data reveals AI-drafted grant proposals have higher NIH success rates but lower novelty scores. Combined with the six-application annual cap and AI ban, the landscape for researchers is shifting fast.
Read article